Mercado fechado

STAAR Surgical Company (STAA)

NasdaqGM - NasdaqGM Preço em Tempo Real. Moeda em USD.
Adicionar à lista
74,78+2,68 (+3,72%)
No fechamento: 04:00PM EDT
74,78 0,00 (0,00%)
Pós-fechamento: 05:00PM EDT

STAAR Surgical Company

25651 Atlantic Ocean Drive
Lake Forest, CA 92630
United States
626 303 7902
https://www.staar.com

Setor(es)Healthcare
IndústriaMedical Instruments & Supplies
Funcionários Integrais692

Principais Executivos

NomeTítuloPagarExercidoNascido em
Ms. Caren L. MasonCEO, Pres & Director1,97M35,32M1954
Mr. Patrick F. WilliamsChief Financial Officer934,82kN/A1973
Dr. Keith HollidayChief Technology Officer822,97k1,13M1963
Mr. Hans-Martin BlickensdoerferSr. VP of Commercial Operations and Director of Markets - Europe & China756,58k20,54M1965
Dr. Scott D. Barnes M.D.Chief Medical Officer874,46k2,12M1963
Mr. Brian MooreVP of Investor, Media Relations & Corp. Devel.N/AN/AN/A
Mr. Samuel J. GestenChief Legal Officer & Corp. Sec.N/AN/A1962
Mr. James FranceseSr. VP of Commercial Operations - North America & APACN/AN/A1964
Joanne Egamino Ph.D.Global Head of Clinical OperationsN/AN/AN/A
Mr. Philippe SubrinVP of Collamer Lens Manufacturing & GM of Nidau OperationsN/AN/A1964
Os valores são a partir de 31 de dezembro de 2021, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em USD.

Descrição

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Governança Corporativa

O QualityScore de governança da ISS da STAAR Surgical Company a partir de 1 de junho de 2022 é 4. As principais pontuações para Auditoria são: 7; Conselho: 2; Direitos de Acionistas: 6; Compensação: 5.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.